Indian Pharma Market Grew 12.1% In August, AWACS Report

New Delhi : Indian pharmaceutical market (IPM) grew 12.1% in value and 4.8% in volumes, in the month of August on back of strong growth across all the therapy areas, according to market research firm AWACS.

IPM saw sales of Rs 16,239 crore during August.

The wholesale price index (WPI) inflation linked price hike allowed by the government has helped the pharma industry to increase by 10% on drugs under price control, along with monsoon linked infectious diseases.

The fastest growing categories are cardiac which grew at 13%, anti-infectives – 13% and gastrointestinal – 12%. Anti-diabetes and vitamins grew 9% respectively.

Augmentin of GSK, Glycomet of USV and Mixtard of Abbott, remain top-3 selling brands in India.

  • Related Posts

    • Pharma
    • July 22, 2025
    • 108 views
    DGFT Extends Deadline on Application for Export of Pharma Grade Sugar

    The Directorate General of Foreign Trade ( DGFT ) has notified an extension in the deadline for submitting applications for the export of Pharma Grade Sugar. This was communicated through Trade Notice…

    • Pharma
    • July 16, 2025
    • 535 views
    Aurobindo, Cipla, Viatris to make, market long-acting injectable HIV drug

    Generic drugmakers Aurobindo Pharma, Cipla and Viatris will develop, manufacture and supply long-acting injectable cabotegravir (CAB LA) for HIV treatment in 133 countries. This follows ViiV Healthcare, a company focused…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    10, 000 Km is just a Number for Intercontinental Tele Surgery by SSIMantra

    10, 000 Km is just a Number for Intercontinental Tele Surgery by SSIMantra

    DGFT Extends Deadline on Application for Export of Pharma Grade Sugar

    DGFT Extends Deadline on Application for Export of Pharma Grade Sugar

    Bihar Healthcare is poised to be embraced by Robotic Surgery Mantra

    Bihar Healthcare is poised to be embraced by Robotic Surgery Mantra

    Aurobindo, Cipla, Viatris to make, market long-acting injectable HIV drug

    Aurobindo, Cipla, Viatris to make, market long-acting injectable HIV drug